JSPR News | Roxom Stocks

1 BTC

=

- USD

Loading market data...

JS

Mkt Cap

$17.7M

Volume

238.27K

Next Earnings

November 9th

Chart Financials Earnings News About Insider Filings

Deal Dispatch: Jasper Therapeutics For Sale, RobinHood Completes $180 Million WonderFi Acquisition, Long John Silver's Franchisee To LiquidateMultiple M&A transactions and strategic reviews dominated the deal landscape. Jasper Therapeutics is exploring a sale or merger, Robinhood completed its $180 million acquisition of Canadian crypto platform WonderFi, Salesforce acquired Contentful, and Wellington Management purchased The Hartford Funds for $1.9 billion. Meanwhile, several companies including Long John Silver's franchisee and Please & Thank You filed for bankruptcy.Benzinga · Jun 5, 2026

Jasper Therapeutics Reports Positive Updated Data from Briquilimab Studies in Chronic Spontaneous UrticariaJasper Therapeutics reported positive updated clinical data from its BEACON Phase 1b/2a study and open-label extension study of briquilimab for chronic spontaneous urticaria (CSU). The drug demonstrated rapid disease control with 67% of additional BEACON patients achieving complete response at 12 weeks and 75% of CSU participants in the extension study achieving complete response or well-controlled disease. Safety profile remained favorable with low-frequency, predominantly low-grade adverse events. The company plans to initiate a Phase 2b study in the second half of 2026.GlobeNewswire Inc. · Jan 8, 2026

Bragar Eagel & Squire is Investigating Certain Officers and Directors of Driven Brands and Jasper Therapeutics on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmLaw firm investigating potential securities misconduct for Driven Brands and Jasper Therapeutics, alleging false statements about business performance and operational practices.GlobeNewswire Inc. · Nov 23, 2025

Bragar Eagel & Squire, P.C. Reminds Stockholders of Jasper, KBR, Spirit, and Molina of the Upcoming Deadlines and Urges Investors to Contact the FirmLaw firm reminds investors of class action lawsuits against multiple companies, alleging false or misleading statements about business operations, financial conditions, and prospects.GlobeNewswire Inc. · Nov 17, 2025

JSPR DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Jasper Therapeutics, Inc. Investors to Secure Counsel Before Important November 18 Deadline in Securities Class Action – JSPRRosen Law Firm is notifying investors of a securities class action lawsuit against Therapeutics for allegedly making false or misleading statements about manufacturing controls and product prospects during the period of November 30, 2023 to July 3, 2025.GlobeNewswire Inc. · Nov 17, 2025

JSPR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Jasper Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action LawsuitA class action lawsuit has been filed against Jasper Therapeutics alleging false and misleading statements about manufacturing controls, product prospects, and potential regulatory issues during the period of November 30, 2023 to July 3, 2025.GlobeNewswire Inc. · Nov 10, 2025

JSPR IMPORTANT DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Jasper Therapeutics, Inc. Investors to Secure Counsel Before Important November 18 Deadline in Securities Class Action – JSPRRosen Law Firm alerts Jasper Therapeutics investors about a securities class action lawsuit regarding potential misleading statements about manufacturing controls and product prospects during the period of November 30, 2023 to July 3, 2025.GlobeNewswire Inc. · Nov 7, 2025

Deadline Alert: Jasper Therapeutics, Inc. (JSPR) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud LawsuitJasper Therapeutics faces a class action lawsuit alleging securities fraud after revealing issues with a drug product lot that impacted clinical trial results, leading to study halts and significant stock price decline.GlobeNewswire Inc. · Nov 3, 2025

JSPR DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Jasper Therapeutics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – JSPRRosen Law Firm is pursuing a securities class action lawsuit against Therapeutics for allegedly making false and misleading statements about manufacturing controls and product prospects during the period of November 30, 2023 to July 3, 2025.GlobeNewswire Inc. · Oct 31, 2025

DEADLINE ALERT for NX, JSPR, KBR, RICK: Law Offices of Howard G. Smith Reminds Shareholders of Opportunity to Lead Securities Fraud Class ActionsLaw firm alerts shareholders about potential securities fraud class action lawsuits for multiple companies, with allegations of misleading statements and financial misrepresentations across different class periods.GlobeNewswire Inc. · Oct 31, 2025

JS

JSPRJasper Therapeutics, Inc. Common Stock

JSPR

Pay with—

Available Balance0.00

Your PositionYou don't own any JSPR yet.

Related Tickers

Earnings